期刊文献+

E3泛素连接酶对卵巢癌细胞系SKOV3/DDP顺铂耐药性的影响 被引量:1

Effect of E3 isolated by differential display on Cisplatin resistance of SKOV3/DDP cells
下载PDF
导出
摘要 目的探讨E3泛素连接酶(EDD)基因在SKOV3/DDP细胞顺铂耐药中的作用。方法采用RT-PCR和Western blot检测人卵巢癌SKOV3细胞和SKOV3/DDP细胞内EDD表达水平的差异。通过转染EDD-si RNA沉默EDD的表达后,噻唑蓝法检测顺铂对SKOV3/DDP细胞增殖的影响,Annexin V-FITC/PI双染法检测顺铂对细胞凋亡的影响;Western blotting检测髓样细胞白血病-1(Mcl-1)和细胞周期检测点激酶2(CHK2)蛋白表达水平。结果SKOV3细胞EDD的表达水平显著低于卵巢癌耐药细胞SKOV3/DDP(P<0.05)。EDD-si RNA转染24 h后,EDD m RNA和蛋白表达水平均显著低于未转染组(P<0.05);SKOV3/DDP细胞IC50值显著降低(P<0.05),Mcl-1蛋白的表达受到抑制(P<0.05),而CHK2无明显变化(P>0.05)。结论 EDD-si RNA能沉默EDD基因,降低Mcl-1蛋白的表达水平,增强顺铂对SKOV3/DDP细胞的促凋亡作用,降低SKOV3/DDP细胞对顺铂的耐药性,有效恢复SKOV3/DDP细胞顺铂敏感性。 Objective To discuss the effect of E3 isolated by differential Display (EDD) on Cisplatin resistance of SKOV3/DDP cells. Methods The expression difference of EDD between Human ovarian cancer cells SKOV3 and SKOV3/DDP cells was detected by Western blot and RT-PCR; EDD-siRNA was transfected into SKOV3/DDP cells to silence the expression of EDD, MTT assay was used to detect the chemosensitivity of SKOV3/DDP cells to Cisplatin, the apoptosis induced by Cisplatin was tested by Annexin V-FITC/PI, the protein levels of Mcl-1 and CHK2 was measured by Western blotting. Results The expression of EDD in SKOV3 cells was significantly lower than SKOV3/EDD cells (P〈0.05). EDD expression was successful silenced and the IC50 of SKOV3/DDP cells was significantly decreased at 24 h in EDD-siRNA group compared with the control group (P〈0.05). Conclusion Silencing EDD gene with EDD-siRNA reduce the expression of Mcl-1, enhance the apoptosis in-ducing effect of Cisplatin on SKOV3/DDP cells, depress the Cisplatin resistance of SKOV3/DDP cells and effectively recover SKOV3/DDP cell sensitivity to Cisplatin.
作者 王小特 曹怡
出处 《中国医药导报》 CAS 2015年第26期20-24,共5页 China Medical Herald
关键词 EDD 卵巢癌 顺铂耐药 细胞凋亡 EDD Ovarian cancer Cisplatin resistance Apoptosis
  • 相关文献

参考文献20

  • 1Callaghan MJ, Russell AJ, W oollatt E, et al. Identification of a human HECT family protein with homology to the Drosophila tumor suppressor gene hyperplastic discs[J]. Oncogene, 1998, 17(26) :3479-3491.
  • 2Wasenius VM,Jekunen A, Monni O,et al, Comparative ge?nomic hybridization analysis of chromosomal changes oc?curring during development of acquired resistance to cis?platin in human ovarian carcinoma cells[J]. Genes Chro?mosomes Cancer, 1997, 18( 4) :286-291.
  • 3Fuja TJ, Lin F, Osann KE, et al. Somatic mutations and altered expression of the candidate tumor suppressors CSNK1 epsilon,DLG1 ,and EDDIhHYD in mammary duc?tal carcinoma[J]. Cancer Res, 2004, 64( 3) : 942-951.
  • 4ClancyJL, Henderson MJ, Russell AJ, et al. EDD, the hu?man orthologue of the hyperplastic discs tumour suppres?sor gene, is amplified and overexpressed in cancer[J]. Oncogene,2003,22(32):5070-5081.
  • 5Mori Y, Sato F, Selaru FM, et al. Instabilotyping reveals unique mutational spectra in microsatellite -unstable gas?tric cancers[J]. Cancer Res, 2002,62(13) : 3641-3645.
  • 6Ziebarth A,Zheng H,Bradley A,et al. The ubiquitin ligase EDD mediates platinum resistance and is a target for therapy in epithelial ovarian cancer[J]. Gynecol Oncol,2011, 130 ( 120) : S26-S27.
  • 7O'Brien PM, Davies MJ, ScurryJP, et al. The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous ep?ithelial ovarian cancer and modulates cisplatin resistance in vitro[J]. BrJ Cancer, 2008, 98( 6): 1085-1093.
  • 8Henderson MJ, Munoz MA, Saunders DN, et al. EDD me?diates DNA damage -induced activation of CHK2[J].J BioI Chern, 2006,281 (52) : 39990-40000.
  • 9Bohgaki M, Hakem A, Halaby M, et al. The E3 ligase PIRH2 polyubiquitylates CHK2 and regulates its turnover[J]. Cell Death & Differentiation, 2013, 20(6) :812-822.
  • 10O'Grady S,Finn SP,Cuffe S,et al. The role of DNA re?pair pathways in cisplatin resistant lung cancer[J]. Can?cer Treat Rev ,2014 ,40( 10): 1161-1170.

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部